Alleged Thyroid Cancer Victim Withdraws Motion to Transfer Similar Byetta Lawsuit Filings
A woman whose Byetta lawsuit alleges new-onset thyroid cancer has withdrawn her motion to consolidate similar claims in California federal court, court documents indicate.
According to a Motion filed on February 18th with the U.S. Judicial Panel on Multidistrict Litigation (JPML), a request seeking to coordinate lawsuits alleging thyroid cancer caused by the Type 2 diabetes drug, has been rescinded pending further discussions with Defendants. If and when the motion resumes, Byetta thyoid cancer claims may join a multidistrict litigation underway in the U.S. District Court, Southern District of California, where cases linking the medication to pancreatitis and pancreatic cancer have already been filed. The motion states that 36 cases alleging the development of thyroid cancer are currently pending in federal courts throughout the U.S.
300 Byetta Lawsuit Filings, Claims over Similar Meds Filed in Federal Litigation
Byetta, which belongs to a class of medications referred to as incretin mimetics, is just one of several products involved in this proceeding. According to a Case List updated on February 19th, a total of 306 claims from individuals alleging serious pancreatic side effects stemming from Januvia, Victoza and other drugs have now been filed in the California court.
Concerns about Byetta’s potential to cause pancreatic cancer, pancreatitis and thyroid cancer have grown steadily since last year, when research began to lend evidence to the association. In April 2013, the Institute for Safe Medicine Practices published an analysis that found 71 Byetta pancreatic cancer reports, 63 instances of pancreatitis and 14 cases of thyroid cancer reported to the U.S. Food and Drug Administration (FDA) over the course of a year. Research also found that incretin mimetics were the most likely to cause pancreatic injuries than any other Type 2 diabetes drug type.
A month earlier, the FDA announced its launch of a safety review involving the medications after the findings of a previously unpublished study showed pre-cancerous cellular changes in diabetics who took Byetta and similar products. The March 2013 alert noted that the investigation was ongoing.
Contact a Byetta Lawyer to Learn More about Filing a Case
If you developed Byetta pancreatic cancer, pancreatitis or another injury after taking the Type 2 diabetes drug, call an attorney at Bernstein Liebhard LLP today at (877) 779-1414. You may be eligible to lawsuit against its manufacturer.